{"title":"Extending PrEP access and coverage in France","authors":"Leslie Grammatico-Guillon, Yazdan Yazdanpanah","doi":"10.1016/s2468-2667(25)00067-2","DOIUrl":null,"url":null,"abstract":"Pre-exposure prophylaxis (PrEP) has become a key strategy for HIV prevention worldwide.<span><span>1</span></span>, <span><span>2</span></span> Since 2016 in France, PrEP—in particular a fixed-dose combination of oral tenofovir disoproxil fumarate and emtricitabine—has been available and fully covered by the French Health Insurance for people considered at high-risk of HIV acquisition. Since its introduction, the number of PrEP initiations has steadily increased, with an estimated 103 407 individuals initiating PrEP up to June, 2024.<span><span>3</span></span>, <span><span>4</span></span> Nevertheless, barriers to uptake and adherence remain, and disparities in PrEP initiation are a concern. In 2023, fewer than 20% of eligible men who have sex with men (MSM) and 2–4% of women at high risk of HIV acquisition were estimated to have initiated PrEP.<span><span>5</span></span>, <span><span>6</span></span>","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"18 1","pages":""},"PeriodicalIF":25.2000,"publicationDate":"2025-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Public Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s2468-2667(25)00067-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Pre-exposure prophylaxis (PrEP) has become a key strategy for HIV prevention worldwide.1, 2 Since 2016 in France, PrEP—in particular a fixed-dose combination of oral tenofovir disoproxil fumarate and emtricitabine—has been available and fully covered by the French Health Insurance for people considered at high-risk of HIV acquisition. Since its introduction, the number of PrEP initiations has steadily increased, with an estimated 103 407 individuals initiating PrEP up to June, 2024.3, 4 Nevertheless, barriers to uptake and adherence remain, and disparities in PrEP initiation are a concern. In 2023, fewer than 20% of eligible men who have sex with men (MSM) and 2–4% of women at high risk of HIV acquisition were estimated to have initiated PrEP.5, 6
Lancet Public HealthMedicine-Public Health, Environmental and Occupational Health
CiteScore
55.60
自引率
0.80%
发文量
305
审稿时长
8 weeks
期刊介绍：
The Lancet Public Health is committed to tackling the most pressing issues across all aspects of public health. We have a strong commitment to using science to improve health equity and social justice. In line with the values and vision of The Lancet, we take a broad and inclusive approach to public health and are interested in interdisciplinary research.
We publish a range of content types that can advance public health policies and outcomes. These include Articles, Review, Comment, and Correspondence. Learn more about the types of papers we publish.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
